HD

Hitansh Doshi

Active Director Designated Partner DIN 10613085
DIN 10613085 First appointment May 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Hitansh Doshi

Data last updated:

Hitansh Doshi is a Designated Partner at Hitan Drugs Llp (since 2024) and Designated Partner at Hitan Life Sciences Llp (since 2024).

DIN 10613085
Primary Designation Designated Partner
First Appointment 01 May 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hitan Drugs Llp ACK-9452
Designated Partner19 Dec 20242024Active
Designated Partner01 May 20242024Active

Board colleagues of Hitansh Doshi

NameDINCompanyDesignation
Shailen Doshi06713250Hitan Drugs LlpDesignated Partner
Tanmay Doshi08631176Hitan Drugs Llp , Hitan Life Sciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Hitan Drugs Llp
Hitan Life Sciences Llp
Premium access

Shareholding and investment profile for Hitansh Doshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hitansh Doshi

Hitansh Doshi currently holds 2 directorships: Hitan Drugs Llp (Designated Partner, since 19 Dec 2024); Hitan Life Sciences Llp (Designated Partner, since 01 May 2024).

Hitansh Doshi was first appointed on 01 May 2024 as Designated Partner at Hitan Life Sciences Llp.

The current boards of Hitansh Doshi's companies include Shailen Doshi (Hitan Drugs Llp), Tanmay Doshi (Hitan Drugs Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available